Investigation Observed Value Unit Biological Reference Interval

Erythrocytes

Haemoglobin (Hb)

(Photometric Measurement)

17.7 gm/dL 13.5-18

Erythrocyte (RBC) Count 5.81 mill/cu.mm 4.7-6.0

PCV (Packed Cell Volume)

(Electrical impedence)

53.6 % 42-52

MCV (Mean Corpuscular Volume)

(Calculated)

92 fL 78-100

MCH (Mean Corpuscular Hb)

(Calculated)

30.5 pg 27-31

MCHC (Mean Corpuscular Hb Concn.)

(Calculated)

33.0 g/dL 32-36

RDW (Red Cell Distribution Width)

(Calculated)

13.8 % 11.5-14.0

Leucocytes

Total Leucocytes (WBC) count 7,400 cells/cu.mm 4000-10500 Neutrophils 67 % 40-80

Lymphocytes 28 % 20-40

Monocytes 3 % 2.0-10

Eosinophils 2 % 1-6

Basophils 0 % 0-2

Platelets

Platelet count 242 10^3 / µl 150-450

CBC Haemogram

Mr. Terin J H

MSc Medical Microbiology

Reference: Dr.REETHU .

Sample Collected At:

KOLLAM

KOLLAM

PROCESSING LOCATION:- Metropolis

Laboratory People Nager-

363,Kadappakada,Kollam

Mr. SIMON SEBASTIAN

Age: 32.0 Year(s) Sex: Male

PID NO: P232300061771

KOLLAM, KOLLAM

Tel No : 903-***-****

PIN No: 691002

VID: 230************

Collected On:

23/06/2023 12:23PM

Registered On:

23/06/2023 12:20 PM

Reported On:

23/06/2023 04:47 PM

Page 1 of 6

Investigation Observed Value Biological Reference Interval HIV( TRIDOT)- SPOT TEST

(Serum,Immunochromatography)

NON REACTIVE Non Reactive

HBSAG SCREENING (HEPACARD)-

SPOT TEST

(Serum,Immunochromatography)

NON REACTIVE Non Reactive

HCV-(TRIDOT)- SPOT TEST

(Serum,Immunochromatography)

Non Reactive Non Reactive

Mr. Terin J H

MSc Medical Microbiology

Reference: Dr.REETHU .

Sample Collected At:

KOLLAM

KOLLAM

PROCESSING LOCATION:- Metropolis

Laboratory People Nager-

363,Kadappakada,Kollam

Mr. SIMON SEBASTIAN

Age: 32.0 Year(s) Sex: Male

PID NO: P232300061771

KOLLAM, KOLLAM

Tel No : 903-***-****

PIN No: 691002

VID: 230************

Collected On:

23/06/2023 12:23PM

Registered On:

23/06/2023 12:20 PM

Reported On:

23/06/2023 04:47 PM

Page 2 of 6

Investigation Observed Value Unit Biological Reference Interval Bleeding & Clotting Time

(Blood)

Bleeding time by Ivy's method 1 min 15 sec min 1-9 Clotting time 4 min 15 sec min 3-11

Interpretation :

1. Bleeding Time is an in vivo test which reflects platelet, vessel wall and some plasma factor participation in the formation of haemostatic plugs within the small blood vessels. In this test the time taken for a standard skin puncture to stop bleeding is measured. Cessation of bleeding indicates the formation of the haemostatic plug. 2. Bleeding time is increased in qualitative abnormalities of platelets, thrombocytopenia, von Willebrands disease and anticoagulant therapy with aspirin.

3. Clotting time measures the time required for clot formation. 4. An increased clotting time is seen in deficiencies of the clotting factors or depleted fibrinogen. 5. Prothrombin time (PT), activated partial thromboplastin time (APTT) and platelet count are a better primary screen for bleeding disorders.

Mr. Terin J H

MSc Medical Microbiology

Reference: Dr.REETHU .

Sample Collected At:

KOLLAM

KOLLAM

PROCESSING LOCATION:- Metropolis

Laboratory People Nager-

363,Kadappakada,Kollam

Mr. SIMON SEBASTIAN

Age: 32.0 Year(s) Sex: Male

PID NO: P232300061771

KOLLAM, KOLLAM

Tel No : 903-***-****

PIN No: 691002

VID: 230************

Collected On:

23/06/2023 12:23PM

Registered On:

23/06/2023 12:20 PM

Reported On:

23/06/2023 04:47 PM

Page 3 of 6

Investigation Observed Value Unit Biological Reference Interval Haemogram, advanced

ESR - Erythrocyte Sedimentation Rate

(citrate Blood,Manual Westergren)

3 mm/hr 0-15

Method: Manual Westergren

Interpretation:

1. It indicates presence and intensity of an inflammatory process, never diagnostic of a specific disease. Changes are more significant than a single abnormal test.

2. It is a prognostic test and used to monitor the course or response to treatment of diseases like tuberculosis, bacterial endocarditis, acute rheumatic fever, rheumatoid arthritis, SLE, Hodgkins disease, temporal arteritis, polymyalgia rheumatica. 3. It is also increased in pregnancy, multiple myeloma, menstruation, and hypothyroidism. Mr. Terin J H

MSc Medical Microbiology

Reference: Dr.REETHU .

Sample Collected At:

KOLLAM

KOLLAM

PROCESSING LOCATION:- Metropolis

Laboratory People Nager-

363,Kadappakada,Kollam

Mr. SIMON SEBASTIAN

Age: 32.0 Year(s) Sex: Male

PID NO: P232300061771

KOLLAM, KOLLAM

Tel No : 903-***-****

PIN No: 691002

VID: 230************

Collected On:

23/06/2023 12:23PM

Registered On:

23/06/2023 12:20 PM

Reported On:

23/06/2023 04:47 PM

Page 4 of 6

Investigation Observed Value Unit Biological Reference Interval Glucose Random

(Serum,GOD/POD)

102 mg/dL Normal: < 140

Diabetes mellitus: >= 200

(on more than one occassion)

(American diabetes association

guidelines 2022)

Liver Function Test-2(Mini)

Proteins

Total Protein

(Serum,Biuret reaction -colorimetric, RS)

6.80 g/dL 6.4-8.3

Albumin

(Serum,Bromocresol purple)

3.70 g/dL 3.5-5.2

Globulin

(Serum)

3.10 g/dL 1.8-3.6

A/G Ratio

(Serum)

1.19 1.1-2.2

BilirubinTotal, Direct, IndirectSerum

Bilirubin-Total

(Serum,Diazo Dye Formation - RS)

0.70 mg/dL 0.2-1.2

Bilirubin-Direct

(Serum,Diazo Dye Formation - RS)

0.20 mg/dL 0-0.5

Bilirubin- Indirect

(Serum,Calculated)

0.50 mg/dL 0.1-1.0

SGPT (ALT)

(Serum,Peroxidase oxidation of DLD - RS)

52 U/L 10-45

SGOT (AST)

(Serum,Peroxidase oxidation of DLD - RS)

33 U/L 5-37

Alkaline Phosphatase

(Serum,P-Nitro Phenol Phosphate- RS)

92 U/L 50-136

Gamma GT (GGTP)

(Serum,catalytic activity- RS)

52 U/L 12-64

TSH(Ultrasensitive)

(Serum,ECLIA)

1.45 µIU/mL 0.4-4.5

Interpretation :

1. TSH results between 4.5 to 15 show considerable physiologic & seasonal variation, suggest clinical correlation or repeat testing with fresh sample .

2. TSH results between 0.1 to 0.45 require correlation with patient age & clinical symptoms. As with increasing age, there are marked changes in thyroid hormone production, metabolism & its actions resulting in an increased prevalence of subclinical thyroid disease .

3. TSH values may be transiently altered because of non thyroidal illness like severe infections,liver disease, renal and heart failure,severe burns, trauma and surgery etc .

4. Drugs that decrease TSH values e.g:L-dopa,Glucocorticoid Drugs that increase TSH values e.g Iodine,Lithium,Amiodarone. Mr. Terin J H

MSc Medical Microbiology

Reference: Dr.REETHU .

Sample Collected At:

KOLLAM

KOLLAM

PROCESSING LOCATION:- Metropolis

Laboratory People Nager-

363,Kadappakada,Kollam

Mr. SIMON SEBASTIAN

Age: 32.0 Year(s) Sex: Male

PID NO: P232300061771

KOLLAM, KOLLAM

Tel No : 903-***-****

PIN No: 691002

VID: 230************

Collected On:

23/06/2023 12:23PM

Registered On:

23/06/2023 12:20 PM

Reported On:

23/06/2023 04:47 PM

Page 5 of 6

-- End of Report --

Investigation Observed Value Unit Biological Reference Interval HbA1C- Glycated Haemoglobin

(Nephelometry)

5.6 % Non-diabetic: <= 5.6

Pre-diabetic: 5.7-6.4

Diabetic: >= 6.5

Estimated Average Glucose (eAG) 114.02 mg/dL

Interpretation & Remark:

1. HbA1c is used for monitoring diabetic control. It reflects the estimated average glucose (eAG). 2. HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 2017, for diagnosis of diabetes using a cut-off point of 6.5%.

3. Trends in HbA1c are a better indicator of diabetic control than a solitary test. 4. Low glycated haemoglobin(below 4%) in a non-diabetic individual are often associated with systemic inflammatory diseases, chronic anaemia(especially severe iron deficiency & haemolytic), chronic renal failure and liver diseases. Clinical correlation suggested.

5. To estimate the eAG from the HbA1C value, the following equation is used: eAG(mg/dl) = 28.7*A1c-46.7 6. Interference of Haemoglobinopathies in HbA1c estimation. A. For HbF > 25%, an alternate platform (Fructosamine) is recommended for testing of HbA1c. B. Homozygous hemoglobinopathy is detected, fructosamine is recommended for monitoring diabetic status C. Heterozygous state detected (D10/ turbo is corrected for HbS and HbC trait). 7. In known diabetic patients, following values can be considered as a tool for monitoring the glycemic control. Excellent Control - 6 to 7 %, Fair to Good Control - 7 to 8 %, Unsatisfactory Control - 8 to 10 % and Poor Control - More than 10 % . Note : Hemoglobin electrophoresis (HPLC method) is recommended for detecting hemoglobinopathy.

(EDTA Whole Blood)

HbA1C- Glycated Haemoglobin,

Reports to follow - Kindly await following pending reports : Investigation : Status

Prothrombin Time (PT) Pending

Mr. Terin J H

MSc Medical Microbiology

Reference: Dr.REETHU .

Sample Collected At:

KOLLAM

KOLLAM

PROCESSING LOCATION:- Metropolis

Laboratory People Nager-

363,Kadappakada,Kollam

Mr. SIMON SEBASTIAN

Age: 32.0 Year(s) Sex: Male

PID NO: P232300061771

KOLLAM, KOLLAM

Tel No : 903-***-****

PIN No: 691002

VID: 230************

Collected On:

23/06/2023 12:23PM

Registered On:

23/06/2023 12:20 PM

Reported On:

23/06/2023 04:47 PM

Page 6 of 6

Contact this candidate